# Hashim U. Ahmed

Source: https://onco.cc/people/hashim-ahmed/  
OnCo record `hashim-ahmed` (Person). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)"; commercial use needs a licence.

## TL;DR

Led PROMIS, the trial that showed MRI can safely spare a quarter of men from prostate biopsy.

## Summary

Hashim Ahmed (Imperial College London) was chief investigator of PROMIS, which showed multiparametric MRI has far higher sensitivity for clinically significant prostate cancer than TRUS biopsy and could allow 27% of men to avoid biopsy altogether. He leads focal therapy trials of HIFU and cryotherapy and the PART and CHRONOS studies comparing focal and radical treatment.

## Fields

- Kind: Person
- Last checked: 2026-09-10
- Tags: prostate; imaging; focal-therapy
- Role: Chair of Urology, Imperial College London
- Specialisms: Prostate cancer diagnostics; Focal therapy; HIFU; Diagnostic trials

## Sources

- PubMed: https://pubmed.ncbi.nlm.nih.gov/?term=Ahmed%20HU%5BAuthor%5D%20prostate%20PROMIS%20OR%20focal

## Connected records

- cancers: [Prostate cancer](https://onco.cc/cancers/prostate/)
- technologies: [Focused ultrasound & histotripsy](https://onco.cc/technologies/hifu-histotripsy/), [MRI](https://onco.cc/technologies/mri/)
- institutions: [Imperial College Healthcare NHS Trust / Imperial College London Cancer Research](https://onco.cc/institutions/imperial-cancer-centre/)
- trials: [PRECISION](https://onco.cc/trials/precision-mri/), [PROMIS](https://onco.cc/trials/promis/), [TRANSFORM](https://onco.cc/trials/transform-prostate/)
- people: [Caroline Moore](https://onco.cc/people/caroline-moore/), [Rakesh Heer](https://onco.cc/people/rakesh-heer/)

---
JSON: https://onco.cc/api/v1/entities/hashim-ahmed.json